|
|
Volumn 336, Issue 7655, 2008, Pages 1246-1248
|
|
Erratum: Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: Summary of NICE guidance (BMJ (Online) (2008) 336 (1246) DOI 10.1136/bmj.39554.624086.AD);Guidelines. Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: Summary of NICE guidance
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EZETIMIBE;
LIPID;
PRAVASTATIN;
SIMVASTATIN;
ANTILIPEMIC AGENT;
CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CHEMICAL MODIFICATION;
HYPERCHOLESTEROLEMIA;
LIFESTYLE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SHORT SURVEY;
ADULT;
BLOOD;
COUNSELING;
FEMALE;
HUMAN;
MALE;
METHODOLOGY;
PATIENT EDUCATION;
PRACTICE GUIDELINE;
REVIEW;
ADULT;
ANTILIPEMIC AGENTS;
CARDIOVASCULAR DISEASES;
CHOLESTEROL;
COUNSELING;
FEMALE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LIFE STYLE;
MALE;
PATIENT EDUCATION AS TOPIC;
PRACTICE GUIDELINES AS TOPIC;
RISK ASSESSMENT;
|
|
EID: 44849094191
PISSN: 09598146
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.g4718 Document Type: Erratum |
|
Times cited : (79)
|
|
References (6)
|
